← Leaderboards
Carey E Gleason
University Of Wisconsin-Madison
$24,542,292
Attributed
$35,391,966
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,391,966 · 6
By mechanism
R01$20,589,705 · 2
RF1$11,054,485 · 1
P30$3,086,883 · 2
K23$660,893 · 1
Top collaborators
- Kristen Jacklin4 shared
- Tassy Parker4 shared
- Kejal Kantarci2 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Sissel Schroeder$59,339
- Sarah E Tate$12,594
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposDementiaParticipantS DiseaseWisconsinCommunitiesBiological MarkersS Disease RiskCohortPre-ClinicalRaceCollectionFundingMiddle AgeCognitionAreaRecruitS Disease Related DementiaAfrican AmericanCognitiveProgramsAdultHealth DisparityCognitive Change
Grant awards (27)
African Americans Fighting Alzheimerâs in Midlife (AA-FAIM)$2,627,099
R01 · FY2025 · AG · contact PI
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project$2,046,479
R01 · FY2025 · AG
Core F - Community Partnership Core$427,625
P30 · FY2025 · AG · contact PI
African Americans Fighting Alzheimerâs in Midlife (AA-FAIM)$2,701,626
R01 · FY2024 · AG · contact PI
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project$2,094,019
R01 · FY2024 · AG
Core F - Inclusion of Underrepresented Groups Core$427,625
P30 · FY2024 · AG · contact PI
African Americans Fighting Alzheimerâs in Midlife (AA-FAIM)$2,744,632
R01 · FY2023 · AG · contact PI
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project$2,042,461
R01 · FY2023 · AG
Inclusion of Under-Represented Groups Core$295,672
P30 · FY2023 · AG · contact PI
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project$1,800,689
R01 · FY2022 · AG
Inclusion of Under-Represented Groups Core$546,510
P30 · FY2022 · AG · contact PI
African AMERICANS Fighting Alzheimer's In Midlife$1,177,042
R01 · FY2021 · AG · contact PI
Inclusion of Under-Represented Groups Core$746,287
P30 · FY2021 · AG · contact PI
African AMERICANS Fighting Alzheimer's In Midlife$753,871
R01 · FY2020 · AG · contact PI
Admin Supplement - Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy$415,612
RF1 · FY2020 · AG
Inclusion of Under-Represented Groups Core$344,517
P30 · FY2020 · AG · contact PI
African AMERICANS Fighting Alzheimer's In Midlife$317,943
R01 · FY2020 · AG · contact PI
African AMERICANS Fighting Alzheimer's In Midlife$757,573
R01 · FY2019 · AG · contact PI
Inclusion of Under-Represented Groups Core$298,647
P30 · FY2019 · AG · contact PI
Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy$10,638,873
RF1 · FY2017 · AG
African AMERICANS Fighting Alzheimer's In Midlife$761,288
R01 · FY2017 · AG · contact PI
African AMERICANS Fighting Alzheimer's In Midlife$764,983
R01 · FY2016 · AG · contact PI
Alzheimer's Disease: Potential Benefit of Isoflavones$138,486
K23 · FY2008 · AG · contact PI
Alzheimer's Disease: Potential Benefit of Isoflavones$135,239
K23 · FY2007 · AG · contact PI
Alzheimer's Disease: Potential Benefit of Isoflavones$132,087
K23 · FY2006 · AG · contact PI
Alzheimer's Disease: Potential Benefit of Isoflavones$69,026
K23 · FY2005 · AG
Alzheimer's Disease: Potential Benefit of Isoflavones$186,055
K23 · FY2004 · AG